Abstract

BackgroundBoth in endemic countries and in imported malaria, changes in total and differential leukocyte count during Plasmodium falciparum infection have been described. To study the exact dynamics of differential leukocyte counts and their ratios, they were monitored in a group of healthy non-immune volunteers in two separate Controlled Human Malaria Infection (CHMI) studies.MethodsIn two CHMI trials, CHMI-a and CHMI-b, 15 and 24 healthy malaria-naïve volunteers, respectively, were exposed to bites of infected mosquitoes, using the P. falciparum research strain NF54 and the novel clones NF135.C10 and NF166.C8. After mosquito bite exposure, twice-daily blood draws were taken to detect parasitaemia and to monitor the total and differential leukocyte counts. All subjects received a course of atovaquone–proguanil when meeting the treatment criteria.ResultsA total of 39 volunteers participated in the two trials. Thirty-five participants, all 15 participants in CHMI-a and 20 of the 24 volunteers in CHMI-b, developed parasitaemia. During liver stage development of the parasite, the median total leukocyte count increased from 5.5 to 6.1 × 109 leukocytes/L (p = 0.005), the median lymphocyte count from 1.9 to 2.2 (p = 0.001) and the monocyte count from 0.50 to 0.54 (p = 0.038). During the subsequent blood stage infection, significant changes in total and differential leukocyte counts lead to a leukocytopenia (nadir median 3.3 × 109 leukocytes/L, p = 0.0001), lymphocytopenia (nadir median 0.7 × 109 lymphocytes/L, p = 0.0001) and a borderline neutropenia (nadir median 1.5 × 109 neutrophils/L, p = 0.0001). The neutrophil to lymphocyte count ratio (NLCR) reached a maximum of 4.0. Significant correlations were found between parasite load and absolute lymphocyte count (p < 0.001, correlation coefficient − 0.46) and between parasite load and NLCR (p < 0.001, correlation coefficient 0.50). All parameters normalized after parasite clearance.ConclusionsDuring the clinically silent liver phase of malaria, an increase of peripheral total leukocyte count and differential lymphocytes and monocytes occurs. This finding has not been described previously. This increase is followed by the appearance of parasites in the peripheral blood after 2–3 days, accompanied by a marked decrease in total leukocyte count, lymphocyte count and the neutrophil count and a rise of the NLCR.

Highlights

  • Both in endemic countries and in imported malaria, changes in total and differential leukocyte count during Plasmodium falciparum infection have been described

  • Data selection This study focused on leukocyte count changes during the liver stage and blood stage of the malaria infection in the participants of Controlled Human Malaria Infection (CHMI)-a and CHMI-b

  • A decrease is observed in total leukocyte, neutrophil, lymphocyte and monocyte count; these changes clearly relate to the occurrence of blood parasitaemia and are not caused by treatment with atovaquone–proguanil, as shown by the control group of four subjects, who remained non-parasitaemic until day 13 after mosquito exposure and were treated with a full course of atovaquone–proguanil

Read more

Summary

Introduction

Both in endemic countries and in imported malaria, changes in total and differential leukocyte count during Plasmodium falciparum infection have been described. Controlled Human Malaria Infection (CHMI) is a wellestablished clinical model that was developed for the evaluation of candidate malaria vaccines and drugs [1]. Changes in total and differential leukocyte count during P. falciparum infection have been described in both clinical studies and CHMI studies previously. In clinical studies, both in endemic countries and in patients with imported malaria [7,8,9,10], the most pronounced change is the decrease of peripheral lymphocytes. One study showed correlations between parasitaemia and both the monocyte to lymphocyte count ratio (MLCR) and neutrophil to monocyte count ratio (NMCR) [11]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call